← Leaderboards
Zheng Xia
Oregon Health & Science University
$1,823,737
Attributed
$2,304,886
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,304,886 · 4
By mechanism
R01$1,645,723 · 2
K01$428,163 · 1
R21$231,000 · 1
Top collaborators
- Alexey V. Danilov1 shared
- Lili Wang1 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Brandon Keith Wilder$4,335,505
- William Messer$6,360,195
- Ruikang Wang$12,102,898
- Julia E Maxson$5,322,132
- George Victor Thomas$5,625,841
Others in their field
Other Emerging Leaders on “Automobile Driving”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Scott Topper · Broad Institute, Inc.$30,147,501
- Leonard Freedman · Leidos Biomedical Research, Inc.$15,624,898
- Ganesh M Babulal · Washington University$11,062,209
- Christopher A. Gaiteri · Rush University Medical Center$9,886,289
Research focus
Automobile DrivingSamplingMolecularGenesSimulationComplexTranscriptome SequencingData SetCellsUntranslated RegionsCell TypeProliferatingTumorData AnalysesBiological ProcessPerformanceTumorigenesisBioinformatics ToolHematologic NeoplasmsGenetic TranscriptionBinding SitesComputing MethodologiesGlioblastomaInnovation
Grant awards (9)
Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation$721,723
R01 · FY2025 · CA
Characterizing phenotype-associated subpopulations from single-cell sequencing data$308,000
R01 · FY2025 · GM · contact PI
Characterizing phenotype-associated subpopulations from single-cell sequencing data$308,000
R01 · FY2024 · GM · contact PI
Characterizing phenotype-associated subpopulations from single-cell sequencing data$308,000
R01 · FY2023 · GM · contact PI
In Silico Screening of Alternative Polyadenylation Regulators in Cancers$142,721
K01 · FY2020 · LM · contact PI
HaemAPA: Characterizing alternative polyadenylation in human blood cells$115,500
R21 · FY2020 · HL · contact PI
In Silico Screening of Alternative Polyadenylation Regulators in Cancers$142,721
K01 · FY2019 · LM · contact PI
HaemAPA: Characterizing alternative polyadenylation in human blood cells$115,500
R21 · FY2019 · HL · contact PI
In Silico Screening of Alternative Polyadenylation Regulators in Cancers$142,721
K01 · FY2018 · LM · contact PI